ОТНОСТНО ТОЗИ ЕПИЗОД

Английски
САЩ

ТРАНСКРИПЦИЯ 🔗

ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ

Търсене в минали епизоди на Innovating Tomorrow's Medicine.

ДРУГИ ЕПИЗОДИ В ТОЗИ ПОДКАСТ

What if we could use gene editing to treat Duchenne Muscular Dystrophy—not just manage symptoms, but address the underlying genetic cause in a scalable, precise way? In this episode, Dr. Courtney Young, CEO of MyoGene Bio, shares how her company is using CRISPR technology to transform the treatment…
What if we could bring the power of precision medicine to more cancer patients, faster—using AI to match patients with the right treatments at the right time? In this episode, Rick Fultz, CEO of Acurion, shares how his company is transforming precision oncology by combining next-generation science …
What if gene editing could treat Duchenne Muscular Dystrophy at its genetic root—not just manage symptoms? Dr. Courtney Young, CEO of MyoGene Bio, is using CRISPR to address the underlying cause of Duchenne in a scalable, precise way that could transform rare disease treatment. 🎙️ Full episode drop…
What if we could destroy cancer cells using a completely novel payload—one that doesn't rely on traditional chemotherapy or even antibody-drug conjugates, but instead uses lytic peptides to obliterate tumors? In this episode, Dr. Stanley Lewis, CEO of A28 Therapeutics, shares how his company is pio…
What if AI could match cancer patients with the right treatments faster—bringing precision medicine to more people who need it? Rick Fultz, CEO of Acurion, is using artificial intelligence to transform how we select cancer therapies, moving beyond traditional biomarkers to comprehensive patient pro…
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от Jeff Trickett, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.